TriSalus Life Cash Over Time
| TLSIW Stock | 1.00 0.07 7.53% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out TriSalus Life Performance and TriSalus Life Correlation. TriSalus |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TriSalus Life. If investors know TriSalus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TriSalus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 1.178 | Quarterly Revenue Growth 0.597 | Return On Assets (1.33) |
The market value of TriSalus Life Sciences is measured differently than its book value, which is the value of TriSalus that is recorded on the company's balance sheet. Investors also form their own opinion of TriSalus Life's value that differs from its market value or its book value, called intrinsic value, which is TriSalus Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TriSalus Life's market value can be influenced by many factors that don't directly affect TriSalus Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TriSalus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if TriSalus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TriSalus Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Cash Analysis
Compare TriSalus Life Sciences and related stocks such as Myomo Inc, QT Imaging Holdings, and Smith Nephew SNATS Cash Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MYO | 2.4 M | 2.4 M | 2.4 M | 2.4 M | 2.4 M | 1 M | 797.2 K | 13 M | 6.5 M | 4.5 M | 12.2 M | 15.5 M | 5.3 M | 6.9 M | 7.5 M |
| QTI | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 455.1 K | 2.4 K | 2.3 K |
| SNN | 134.6 M | 184 M | 178 M | 137 M | 93 M | 120 M | 100 M | 169 M | 365 M | 277 M | 1.8 B | 1.3 B | 350 M | 302 M | 278.3 M |
| WOK | 200.4 K | 200.4 K | 200.4 K | 200.4 K | 200.4 K | 200.4 K | 200.4 K | 200.4 K | 200.4 K | 200.4 K | 508.7 K | 731.2 K | 1.6 M | 1.8 M | 1.9 M |
| XYLO | 22.4 M | 22.4 M | 22.4 M | 22.4 M | 22.4 M | 22.4 M | 22.4 M | 22.4 M | 22.4 M | 22.4 M | 22.4 M | 24 M | 20.2 M | 9.4 M | 15.2 M |
| GMED | 111.7 M | 142.7 M | 212.4 M | 90 M | 82.3 M | 60.2 M | 132.6 M | 118.8 M | 139.7 M | 195.7 M | 239.4 M | 193.1 M | 150.5 M | 467.3 M | 490.7 M |
| HSDT | 9.0 | 9.0 | 9.0 | 9.0 | 418.9 K | 2.6 M | 2.7 M | 5.6 M | 25.6 M | 5.5 M | 3.3 M | 11 M | 14.5 M | 5.2 M | 7.6 M |
| ZIMV | 37 M | 37 M | 37 M | 37 M | 37 M | 37 M | 37 M | 37 M | 37 M | 37 M | 27.4 M | 100.4 M | 89.6 M | 71.5 M | 71.7 M |
| ICAD | 100 K | 4.6 M | 13.9 M | 11.9 M | 32.2 M | 15.3 M | 8.6 M | 9.4 M | 12.2 M | 15.3 M | 27.2 M | 34.3 M | 21.3 M | 21.7 M | 22.8 M |
| IINN | 8 K | 8 K | 8 K | 8 K | 8 K | 8 K | 8 K | 8 K | 8 K | 96 K | 496 K | 23.7 M | 6.8 M | 5 M | 6.6 M |
TriSalus Life Sciences and related stocks such as Myomo Inc, QT Imaging Holdings, and Smith Nephew SNATS Cash description
Cash refers to the most liquid asset of TriSalus Life Sciences, which is listed under current asset account on TriSalus Life Sciences balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from TriSalus Life customers. The amounts must be unrestricted with restricted cash listed in a different TriSalus Life account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.My Equities
My Current Equities and Potential Positions
| TriSalus Life Sciences | TLSIW |
| Classification | Healthcare |
| Location | Colorado; U.S.A |
| Exchange | NASDAQ Exchange |
null 1.0
Additional Tools for TriSalus Stock Analysis
When running TriSalus Life's price analysis, check to measure TriSalus Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TriSalus Life is operating at the current time. Most of TriSalus Life's value examination focuses on studying past and present price action to predict the probability of TriSalus Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TriSalus Life's price. Additionally, you may evaluate how the addition of TriSalus Life to your portfolios can decrease your overall portfolio volatility.